You Position: Home > Paper

Role of PKCβ in the malignant tumors and Enzastaurin,a PKCβ inhibitor

( views:21, downloads:0 )
Author:
No author available
Journal Title:
ACTA PHARMACEUTICA SINICA
Issue:
5
DOI:
10.3321/j.issn:0513-4870.2009.05.002
Key Word:
蛋白激酶Cβ;恶性肿瘤;抑制剂

Abstract: 蛋白激酶Cβ(PKCβ)是一种丝氨酸/苏氨酸蛋白激酶,是细胞内多种信号转导通路的重要成分,参与细胞周期的调控、分化、增殖、凋亡与血管形成等多种生理过程.在许多肿瘤中观察到PKCfl活性增加,如结肠癌、乳腺癌、血液系统肿瘤等,目前临床前和临床试验中研究最多的是选择性PKCfl抑制剂Enzastaurin.本文从PKCβ的结构与功能、PKCp与肿瘤的关系及PKCfl抑制剂Enzastaurin等方面进行综述.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn